Anavex Life Profile

3.16
USD 0.05  1.56%
45%
19%

Anavex Life exotic insider transaction detected

Anavex Life Sciences Corp insider trading alert for general transaction of stock options by Durrant Cameron, Executive Chairman, on July 12, 2018. This event was filed by Anavex Life Sciences Corp with SEC on 2011-02-10. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Anavex Life Summary

Anavex Life Sciences Corp (AVXL) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 10 people. Anavex Life is listed under Business Services category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 137.55 M. Anavex Life Sciences Corp conducts business under Healthcare sector and is part of Business Services industry. This company has 44.66 M outstanding shares of which 6.16 M shares are presently shorted by private and institutional investors with about 9.29 trading days to cover. ANAVEX LIFE SCIEN currently holds about 25.66 M in cash with (11.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Anavex Life Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 3.16HorizonTargetOdds Above 3.16
37.09%30 days 3.16 62.79%
Based on normal probability distribution, the odds of Anavex Life to move above current price in 30 days from now is about 62.79% (This Anavex Life Sciences Corp probability density function shows the probability of Anavex Life Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Edge Wealth Management LlcCommon Shares10 K26 K
Bank Of MontrealCommon Shares5.9 K15 K
Edge Wealth Management LlcCall Options1.3 K9 K
Group One Trading LpPut Options154.1 K425 K
View Anavex Life Diagnostics

Selected Anavex Life Sciences Corp Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Anavex Life Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
94 
Equity ratings for Anavex Life Sciences Corp are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimers disease, other central nervous system diseases, pain, and various cancers. The company was founded in 2006 and is based in New York, New York. Anavex Life operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 10 people. more
Fama & French Business Services
Business Services
Fama & French Classification
Anavex Life Sciences SEC Filings
Anavex Life SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAnavex Life Sciences Corp
CEOChristopher MisslingView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationNEW YORK U.S.A
Business Address51 West 52nd Street
ExchangeBATS Exchange
CIK Number0001314052
CUSIP885875104
SectorHealthcare
IndustryBusiness Services
BenchmarkDOW
Websitewww.anavex.com
Phone844 689 3939
CurrencyUSD - US Dollar

Anavex Life Corporate Directors

Check also Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">